SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to discussions around a potential short squeeze and recent volatility, sparked by news of their expansion into menopause treatments. The stock's price action is seeing a lot of back and forth between bulls and bears. Some traders point to the potential for further gains, while others cite concerns about valuation and management actions.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

ORCL is experiencing significant volatility, driven by discussions around its analyst day and future outlook. The community is debating the credibility of new leadership and the achievability of long-term financial targets, especially regarding AI and cloud revenue, contributing to the stock's price swings. Some traders are seeing opportunity, while others express skepticism about the company's promises.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

Artiva Biotherapeutics is trending after receiving FDA Fast Track designation for its AlloNK therapy in refractory rheumatoid arthritis, sparking optimism for a potential biotech comeback. The community is actively discussing the implications of this designation, potential price targets, and the possibility of a short squeeze. Wedbush analysts have also raised their price target, contributing to the increased interest.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine ($APPS) is trending as investors discuss its potential in the evolving app store landscape, particularly following recent rulings impacting Google's Play Store policies. Community members are speculating on how the company might capitalize on these changes and forge new partnerships, with some drawing comparisons to the AI-driven growth of companies like Applovin. Bullish sentiment is building amidst discussions of potential short squeezes and a multi-year uptrend.

Gitlab, Inc. provides code hosting and collaboration platform services. It offers continuous integration, source code management, out-of-the-box pipelines, agile development, and value stream management. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in Dover, DE.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is trending amidst rumors of a potential takeover bid from Datadog, with the community debating the legitimacy of the reports and potential bidding war with Google. Some investors express concerns about manipulation and the stock's performance, while others highlight the company's growth, margins, and potential synergies in an acquisition. Discussions also cover the impact of AI and the company's competitive positioning against GitHub.

Aptera Motors Corp. is an automotive technology company focused on the development, production, and distribution of energy-efficient, solar-powered, battery-electric vehicles. Its flagship product, the Aptera, is a three-wheeled, two-seat solar vehicle designed to reduce reliance on traditional charging by utilizing integrated solar panels. The company was founded by Steve Fambro and Chris Anthony and is headquartered in San Diego, CA.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

Aptera Motors ($SEV) is trending due to high volatility following its direct listing, with community members actively discussing trading halts and potential market manipulation.  While some investors express excitement about the company's solar EV technology and pre-order demand, others voice concerns about production timelines and the vehicle's design.  The stock's extreme price fluctuations have fueled speculation about short squeezes and long-term potential within the EV sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to levels not seen in over a decade, driven by a potential short squeeze and global demand for bullion. Community discussions revolve around whether the rally is sustainable, with some citing supply shortages and a potential for further gains, while others warn of a possible pullback. The broader context includes concerns about the dollar and traditional safe haven assets.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending as investors discuss its high yield and weekly payouts, with some focusing on reinvesting dividends for compounding returns. Community members are debating the fund's NAV erosion and the sustainability of its distributions, while others highlight its active management and potential for income generation in a volatile market. Recent discussions also touch on potential short squeezes and the impact of broader market trends on the ETF's performance.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci ($CVM) is trending as investors await a potential decision from the Saudi Food and Drug Authority (SFDA) regarding Breakthrough Medicine Designation for Multikine, its cancer immunotherapy, with the review window closing soon. The community is buzzing about the partnership with Dallah Pharma and the potential for Multikine to become available in Saudi Arabia ahead of the US market. Discussions also involve the company's financials, insider activity, and the possibility of a confirmatory study.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending as gold prices surge, driven by safe-haven demand amid economic uncertainty and geopolitical tensions. The community is actively discussing whether this rally is sustainable, with some pointing to potential overextension and others anticipating further upside due to a weakening dollar. Concerns about regional banks and global economic instability are fueling interest in gold as a store of value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
